CYP46A1 and myeloid sarcoma: As the depletion of cholesterol, 24S‐HC and 24S,25‐EC in MS brain white matter suggested a potential metabolic impairment, we investigated the expression of CYP46A1 in donor brain tissue by in situ hybridisation and immunostaining.